Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride vs Metoclopramide for Gastric Emptying in ICU
NCT05496179Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Aug 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of prucalopride in enteral feeding intolerance (EFI) (2 arms), sponsored by Ain Shams University. Primary endpoint: Gastric residual volume at 7 days. Started Aug 2022; status: completed.
02
Drugs
prucalopride
03
Conditions
enteral feeding intolerance (EFI)
Beyond the preview
Go deeper on NCT05496179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05496179.